Skip to main content
OpenTrials
Completed

NCT Number: NCT06110624

The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Palliative Medicine

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Center Groningen, Groningen, Netherlands

Loading trial locations.

About this study

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:

  • General practice
  • Nursing home
  • Hospital:
  • Clinical geriatrics
  • Medical oncology
  • Radiation oncology
  • Pulmonology
  • Cardiology

Exclusion criteria

HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.

GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Treatment and study plan

Survey

Other

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

Primary outcomes

  1. Questions evaluating Intention to Use (IU)

    Time frame: after 5 times use of the MuSt-PC tool within 3 months

    Questions evaluating Intention to Use (IU) (7-point Likert scales)

Secondary outcomes

  1. Questions evaluating other modified TAM domains

    Time frame: after 5 times use of the MuSt-PC tool within 3 months

    Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).

  2. Perceived benefits and disadvantages of using MuSt-PC

    Time frame: after 5 times use within 3 months

    Perceived benefits and disadvantages of using MuSt-PC (open-ended questions).

  3. Suggestions to improve the MuSt-PC CDSS

    Time frame: after 5 times of the MuSt-PC tool within 3 months

    Suggestions to improve the MuSt-PC CDSS (open-ended question).

  4. An overview of the content of questions of participating GHCPs regarding MuSt-PC use.

    Time frame: after 5 times use within 3 months

    An overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).

  5. Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.

    Time frame: after 5 times use within 3 months

    Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated

  6. Mean scores of HCPs adherence to CDSS recommendations

    Time frame: after 5 times use of the MuSt-PC tool within 3 months

    Mean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC)

Other outcomes

  1. A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use

    Time frame: after 5 times use of the MuSt-PC tool within 3 months

    A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use:

    • Insufficient IU is defined as a sum score of ≤12 for the 3 questions that measure Intention to Use by the modified TAM questionnaire (maximum sum score 21)
    • Insufficient PU is defined as a sum score of ≤24 for the 6 questions that measure PU by the modified TAM questionnaire (maximum sum score 42)
    • insufficient PEU is defined as a sum score of ≤24 for the 6 items that measure PEU by the modified TAM questionnaire (maximum sum score 42). (see Appendix G) Six to twelve GHCPs with a sum score of ≤12 (IU) and/or ≤24 (PU and/or PEU) will be invited to participate.

Sponsors and collaborators

Lead sponsor

University Medical Center Groningen

Other

Registry information

Official study title

The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 31, 2023
Registry last updated
Nov 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.